Reducing oral steroid intolerability and drug costs for acute wheezers: A retrospective evaluation of a clinical management algorithm in a Pediatric Emergency Department.
Gail Lindsey DavisonJosh RuddellMichelle TroutonRoisin McDonaldBen KennedyVikki O'NeillJoseph McCannBrigitte BartholomeHeather SteenMichael D ShieldsStephen MullenPublished in: Pediatric pulmonology (2023)
Reduced intolerability and substantial cost savings can be achieved by implementing a structured acute pediatric wheeze algorithm and modifying the OCS to single-dose dexamethasone (300 mcg/kg).